(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 6.85% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.62%.
Innospec's revenue in 2026 is $1,790,400,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $47,119,192,911, with the lowest IOSP revenue forecast at $44,138,836,224, and the highest IOSP revenue forecast at $49,114,307,718.
In 2027, IOSP is forecast to generate $50,050,287,504 in revenue, with the lowest revenue forecast at $46,478,785,689 and the highest revenue forecast at $52,464,130,110.